Application Due Date: August 10, 2023
The purpose of this Notice of Funding Opportunity (NOFO) is to support dissemination and implementation (D&I) research focused on increasing access to and uptake of coronavirus disease 2019 (COVID-19) testing interventions – with the goal of reducing COVID-19 disparities and promoting health equity among underserved and vulnerable populations. This NOFO will support D&I research on how evidence-based practices, interventions, and policies are effectively translated to and used in real-world settings. Projects may evaluate the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, or seek to understand the “de-implementation” of practices that are ineffective, low-value, or inequitable. Interventions developed through the Rapid Acceleration of Diagnostics – Underserved Populations (RADx®-UP) initiative are encouraged, but not required.
The funding for this program is provided from the American Rescue Plan Act of 2021, Public Law 117-2.
Topics: Clinical Presentation of Infection, ARDS, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Pneumonia, Sensory, Clinical Trial, Co-Morbidities, Asthma, Cancer, Cardiovascular Disease, Cirrhosis, COPD, COVID-19, Diabetes, Gastroesophageal Reflux Disease (GERD), Hidradentis Supporativa, Immune Disorders, HIV, Immunosuppression, Inflammation, Rheumatoid Disorders, Neurological Disorders, Substance Abuse, Community Engagement, Computational Analysis, Diagnostics, Diagnostics Development, Diagnostic Efficacy, Diagnostic Reliability, Diagnostic Scalability, Economic Impact, Education and Training, ELSI (Ethical, Legal, and Social Implications), Environmental Health, Epidemiology, Clinical History, Clinical Outcome, Contact Tracing, Incidence, Risk Factors, Surveillance, Transmission, Health Disparities, Healthcare Implementation, Mental Health, Psychology, Mobile Health, App, Telemedicine, Wearables, Occupational Health, Oral Science / Dentistry, Prevention, PPE, Social Distancing, Prognostics, Research Site, Community-based, Vaccine Development, Vaccine Efficacy, Vaccine Reliability, Vaccine Scalability, Vaccines, Vaccine Hesitancy, Social Determinants of Health, Target Population, Children, Deaf Persons, Elderly, Homeless Persons, Pregnant Women, Prisoners, Service Workers, Teens, Treatments, Treatment Efficacy, Treatment Reliability, Treatment Scalability, Drugs, Antibody-based Treatment, Convalescent Serum, Drug Targets